Granted Patent
B2
US 12,252,740 · App. 18/352,957 · Granted Mar 18, 2025
Multiomic analysis device and methods of use thereof
Inventors:
Sandor Kovacs (Encinitas, CA); Eli N. Glezer (Del Mar, CA); Christopher Frye (San Diego, CA)
Assignee:
Singular Genomics Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A device comprising: a sample stage configured to be coupled to a microplate receiver; a microplate receiver configured to be coupled to a microplate; at least one heating element thermally coupled to the microplate receiver; a fluidics dispenser configured to dispense one or more reagents into the microplate; and an imaging system configured to detect one or more features in the microplate; and a structure physically coupled to the sample stage, the heating element, the fluidics dispenser, and the imaging system.
Claims (24)
1. A device comprising:
a sample stage configured to be coupled to a solid support comprising a plurality of reaction chambers, wherein each reaction chamber comprises a tissue section comprising a plurality of fluorophores bound to biomolecules in the tissue section;
a heating element thermally coupled to the sample stage capable of heating the reaction chambers to 40° C. to 80° C.;
an imaging system configured to detect one or more fluorescent signals; and
a lid configured to enclose the solid support, wherein the lid is attached to the device via a hinge assembly configured to move the lid between an open and closed position.
2. The device of claim 1 , wherein the imaging system comprises at least one of a kinematic mount and an auto-leveler mechanism.
3. The device of claim 1 , wherein the imaging system comprises at least one of a three-dimensional imager, a TDI scanner, a laser, a camera, an autofocus, and a transilluminator.
4. The device of claim 1 , further comprising at least one reservoir physically coupled to the device.
5. The device of claim 4 , wherein the at least one reservoir comprises at least one of a waste reservoir, a sequencing reagent reservoir, a clustering reagent reservoir, and a wash solution reservoir.
6. The device of claim 1 , wherein the device is configured to effectuate temperature cycling.
7. The device of claim 1 , wherein the device comprises an integrated system of one or more interconnected chambers, one or more ports, and one or more channels in fluid communication and configured for carrying out an analytical reaction or process, either alone or in cooperation with an appliance or instrument that provides support functions.
8. The device of claim 7 , wherein the support functions comprise at least one of sample introduction, fluid and/or reagent driving means, temperature control, detection systems, data collection and integration systems, and are configured to determine a nucleic acid sequence of a template polynucleotide.
9. The device of claim 1 , wherein each tissue section is about 5 μm to about 12 μm.
10. The device of claim 1 , wherein each tissue section comprises an amplification product comprising multiple copies of a nucleic acid sequence.
11. The device of claim 10 , wherein the amplification product is attached to a protein in the tissue section.
12. The device of claim 1 , wherein each tissue section comprises a plurality of spectrally distinct fluorophores.
13. The device of claim 12 , further comprising a display and a graphical user interface.
14. The device of claim 13 , wherein the sample stage is capable of moving in an xy plane.
15. The device of claim 14 , wherein the sample stage is capable of translating in an xy plane, and the imaging system comprises an image sensor is capable of moving along a polar angle formed between a z axis and a normal vector of the xy plane.
16. The device of claim 1 , wherein each tissue section comprises further comprises an eosin stain or a 4′, 6-diamidino-2-phenylindole (DAPI) stain.
17. The device of claim 1 , wherein the imaging system comprises a laser and a line generator.
18. The device of claim 17 , wherein the imaging system comprises a TDI sensor array.
19. The device of claim 1 , wherein the imaging system is configured to continuously scan the reaction chambers.
20. The device of claim 19 , wherein the imaging system is configured to continuously scan the reaction chambers at 10 mm 2 /sec, 20 mm 2 /sec, 30 mm 2 /sec, 40 mm 2 /sec, or 50 mm 2 /sec.
Assignments (2)
SECURITY INTEREST
Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 6, 2023
From: KOVACS, SANDOR; GLEZER, ELI N.; FRYE, CHRISTOPHER
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 065151/0625 →
Continuity (4)
Continuation
PCTUS2022027630
· May 4, 2022
Provisional Application
63184684
· May 5, 2021
References Cited (292)
US 4318846A
· Khanna et al.
· 1982
[cited by applicant]
US 4792520A
· Stambrook et al.
· 1988
[cited by applicant]
US 5034506A
· Summerton et al.
· 1991
[cited by applicant]
US 5066580A
· Lee
· 1991
[cited by applicant]
US 5188934A
· Menchen et al.
· 1993
[cited by applicant]
US 5235033A
· Summerton et al.
· 1993
[cited by applicant]
US 5366860A
· Bergot et al.
· 1994
[cited by applicant]
US 5538724A
· Butcher
· 1996
[cited by examiner]
US 5599675A
· Brenner
· 1997
[cited by applicant]
US 5688648A
· Mathies et al.
· 1997
[cited by applicant]
US 5750341A
· Macevicz
· 1998
[cited by applicant]
US 5763594A
· Hiatt et al.
· 1998
[cited by applicant]
US 5800996A
· Lee et al.
· 1998
[cited by applicant]
US 5808045A
· Hiatt et al.
· 1998
[cited by applicant]
US 5847162A
· Lee et al.
· 1998
[cited by applicant]
US 5872244A
· Hiatt et al.
· 1999
[cited by applicant]
US 6210891B1
· Nyren et al.
· 2001
[cited by applicant]
US 6218122B1
· Friend et al.
· 2001
[cited by applicant]
US 6232465B1
· Hiatt et al.
· 2001
[cited by applicant]
US 6258568B1
· Nyren
· 2001
[cited by applicant]
US 6271022B1
· Bochner
· 2001
[cited by examiner]
US 6274320B1
· Rothberg et al.
· 2001
[cited by applicant]
US 6365367B1
· Friedman
· 2002
[cited by examiner]
US 6664079B2
· Ju et al.
· 2003
[cited by applicant]
US 7057026B2
· Barnes et al.
· 2006
[cited by applicant]
US 7264929B2
· Barnes et al.
· 2007
[cited by applicant]
US 7271952B2
· Suzuki et al.
· 2007
[cited by applicant]
US 7390463B2
· He et al.
· 2008
[cited by applicant]
US 7541444B2
· Milton et al.
· 2009
[cited by applicant]
US 8003354B2
· Shen et al.
· 2011
[cited by applicant]
US 8039817B2
· Feng et al.
· 2011
[cited by applicant]
US 8178360B2
· Barnes et al.
· 2012
[cited by applicant]
US 8241573B2
· Banerjee et al.
· 2012
[cited by applicant]
US 8551710B2
· Bernitz et al.
· 2013
[cited by applicant]
US 9371598B2
· Chee
· 2016
[cited by applicant]
US 9556473B2
· Bernitz et al.
· 2017
[cited by applicant]
US 9593365B2
· Frisen et al.
· 2017
[cited by applicant]
US 9598723B2
· Ammann et al.
· 2017
[cited by applicant]
US 20010054691A1
· Park
· 2001
[cited by examiner]
US 20020159919A1
· Churchill
· 2002
[cited by examiner]
US 20030032024A1
· Lizardi et al.
· 2003
[cited by applicant]
US 20030082556A1
· Kaufman et al.
· 2003
[cited by applicant]
US 20030143536A1
· Lizardi
· 2003
[cited by applicant]
US 20050089860A1
· Arita
· 2005
[cited by applicant]
US 20050208644A1
· Takiguchi et al.
· 2005
[cited by applicant]
US 20060050376A1
· Houston et al.
· 2006
[cited by applicant]
US 20060292559A1
· Reddy et al.
· 2006
[cited by applicant]
US 20090298718A1
· Denman et al.
· 2009
[cited by applicant]
US 20100055733A1
· Lutolf et al.
· 2010
[cited by applicant]
US 20110059865A1
· Smith et al.
· 2011
[cited by applicant]
US 20110223585A1
· Gullberg et al.
· 2011
[cited by applicant]
US 20120301886A1
· Farrell et al.
· 2012
[cited by applicant]
US 20140056811A1
· Jacob et al.
· 2014
[cited by applicant]
US 20140057799A1
· Johnson et al.
· 2014
[cited by applicant]
US 20160257993A1
· Fu et al.
· 2016
[cited by applicant]
US 20160369329A1
· Cai et al.
· 2016
[cited by applicant]
US 20170107563A1
· Samusik et al.
· 2017
[cited by applicant]
US 20190017106A1
· Frisen et al.
· 2019
[cited by applicant]
US 20190071668A1
· Schmidt et al.
· 2019
[cited by applicant]
US 20190113423A1
· Goodman et al.
· 2019
[cited by applicant]
US 20190155835A1
· Daugharthy
· 2019
[cited by examiner]
US 20190376123A1
· Bobrow et al.
· 2019
[cited by applicant]
US 20200277663A1
· Ramachandran Iyer et al.
· 2020
[cited by applicant]
US 20200277664A1
· Frenz
· 2020
[cited by applicant]
US 20200362334A1
· Regev et al.
· 2020
[cited by applicant]
US 20210039062A1
· Mirkin et al.
· 2021
[cited by applicant]
US 20210108195A1
· Bernate et al.
· 2021
[cited by applicant]
US 20210238662A1
· Bava
· 2021
[cited by applicant]
US 20210382033A1
· Mir
· 2021
[cited by applicant]
US 20210388424A1
· Bava
· 2021
[cited by applicant]
US 20220229044A1
· Feldman et al.
· 2022
[cited by applicant]
US 20230100215A1
· Glezer et al.
· 2023
[cited by applicant]
JP 2005265627A
· 2005
[cited by applicant]
JP 5970959B2
· 2016
[cited by applicant]
WO WO1989010977A1
· 1989
[cited by applicant]
WO WO1996007669A1
· 1996
[cited by applicant]
WO WO2004018497A2
· 2004
[cited by applicant]
WO WO2005039389A2
· 2005
[cited by applicant]
WO WO2008042067A2
· 2008
[cited by applicant]
WO WO2013090360A2
· 2013
[cited by applicant]
WO WO2014030066A2
· 2014
[cited by applicant]
WO WO2017079382A1
· 2017
[cited by applicant]
WO WO2018091676A1
· 2018
[cited by applicant]
WO WO2018148723A1
· 2018
[cited by applicant]
WO WO2019068880A1
· 2019
[cited by applicant]
WO WO2019084062A1
· 2019
[cited by applicant]
WO WO2019199579A1
· 2019
[cited by applicant]
WO WO2019222284A1
· 2019
[cited by applicant]
WO WO2020028194A1
· 2020
[cited by applicant]
WO WO2020056044A1
· 2020
[cited by applicant]
WO WO2020076976A1
· 2020
[cited by applicant]
WO WO2020076979A1
· 2020
[cited by applicant]
WO WO2020096687A1
· 2020
[cited by applicant]
WO WO2020099640A1
· 2020
[cited by applicant]
WO WO2020123309A1
· 2020
[cited by applicant]
WO WO2020160044A1
· 2020
[cited by applicant]
WO WO2022056385A1
· 2022
[cited by applicant]
Agrawal, S. et al. (Nov. 15, 2016). “Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy,”
[cited by applicant]
Ahern, H. (1995) “Biochemical, reagent kits offer scientists good return on investment,”
[cited by applicant]
Alon, S. et al. (Jan. 29, 2021). “Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems,”
[cited by applicant]
Arce, S. H. et al. (Jul. 24, 2013). “Fast and accurate automated cell boundary determination for fluorescence microscopy,”
[cited by applicant]
Auld, D. S. et al. (Jun. 1, 2020). “Microplate Selection and Recommended Practices in High-throughput Screening and Quantitative Biology,” In S. Markossian (Eds.) et al.,
[cited by applicant]
Bains, W. et al. (Dec. 7, 1988). “A novel method for nucleic acid sequence determination,”
[cited by applicant]
Bains, I. et al. (May 28, 2009). “Quantifying the development of the peripheral naive CD4+ T-cell pool in humans,”
[cited by applicant]
Bullinger, L. et al. (Apr. 15, 2004). “Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia,”
[cited by applicant]
Cai, M. (2019). “ Spatial mapping of single cells in human cerebral cortex using DARTFISH: A highly multiplexed method for in situ quantification of targeted RNA transcripts,”
[cited by applicant]
Carow, B. et al. (2019). “Spatial and temporal localization of immune transcripts defines hallmarks and diversity in the tuberculosis granuloma,”
[cited by applicant]
Carpenter, A. E. et al. (Oct. 31, 2006). “CellProfiler: image analysis software for identifying and quantifying cell phenotypes,”
[cited by applicant]
Catuogno, S. et al. (Apr. 8, 2011). “Recent advance in biosensors for microRNAs detection in cancer,”
[cited by applicant]
Chen, F. et al. (Jan. 30, 2015, e-published Jan. 15, 2015). “Expansion microscopy,”
[cited by applicant]
Chen, K. H. et al. (Apr. 24, 2015, e-published Apr. 9, 2015). “RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells,”
[cited by applicant]
Chen, X. et al. (Feb. 28, 2018, e-published Nov. 28, 2017). “Efficient in situ barcode sequencing using padlock probe-based BaristaSeq,”
[cited by applicant]
Christian, A. T. et al. (Dec. 4, 2001, e-published Nov. 27, 2001). “Detection of DNA point mutations and mRNA expression levels by rolling circle amplification in individual cells,”
[cited by applicant]
Daigeler, A. et al. (Jul. 6, 2006). “Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues,”
[cited by applicant]
Denkert, C. et al. (Nov. 1, 2015, e-published Aug. 14, 2015). “Strategies for developing Ki67 as a useful biomarker in breast cancer,”
[cited by applicant]
Dirks, R. M. et al. (Oct. 18, 2004). “Triggered amplification by hybridization chain reaction,”
[cited by applicant]
Drmanac, S. et al. (Jan. 1, 1998). “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,”
[cited by applicant]
Edelman, M. J. et al. (May 1997, e-published Feb. 28, 2002). “The utility of follow-up testing after curative cancer therapy: a critical review and economic analysis,”
[cited by applicant]
El-Sagheer, A. H. et al. (Aug. 21, 2012, e-published Mar. 22, 2012).“Click nucleic acid ligation: applications in biology and nanotechnology,”
[cited by applicant]
Fan, T. et al. (Sep. 2018, e-published Jul. 7, 2018). “Branched rolling circle amplification method for measuring serum circulating micro RNA levels for early breast cancer detection,”
[cited by applicant]
Feeney, R. E. et al. (Apr. 1, 1982). “Chemical modification of proteins: An overview,”
[cited by applicant]
Fijnvandraat, A. C. et al. (Sep. 1, 2002, e-published Sep. 10, 2002). “Nonradioactive in situ detection of mRNA in ES cell-derived cardiomyocytes and in the developing heart,”
[cited by applicant]
Fodor, S. P. et al. (Feb. 15, 1991). “Light-directed, spatially addressable parallel chemical synthesis,”
[cited by applicant]
Fredriksson, S. et al. (Apr. 2007, e-published Mar. 18, 2007). “Multiplexed protein detection by proximity ligation for cancer biomarker validation,”
[cited by applicant]
Fredriksson, S. et al. (May 1, 2002). “Protein detection using proximity-dependent DNA ligation assays,”
[cited by applicant]
Ganusov, V. V. et al. (Dec. 2007, e-published Oct. 26, 2007). “Do most lymphocytes in humans really reside in the gut?,”
[cited by applicant]
Gao, H. et al. (Dec. 2019, e-published Oct. 17, 2019) “Rolling circle amplification for single cell analysis and in situ sequencing,”
[cited by applicant]
Gelali, E. et al. (Apr. 9, 2019). “iFISH is a publically available resource enabling versatile DNA FISH to study genome architecture,”
[cited by applicant]
Gore, A. et al. (Mar. 3, 2011, e-published Mar. 2, 2011). “Somatic coding mutations in human induced pluripotent stem cells,”
[cited by applicant]
Gullberg, M. et al. (May 21, 2004). “Cytokine detection by antibody-based proximity ligation,”
[cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” PNAS USA 105(27):9145-9…
[cited by applicant]
Gyllborg, D. et al. (Nov. 4, 2020, e-published Sep. 29, 2020). “Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue,”
[cited by applicant]
Hagai, T. et al. (Nov. 2018, e-published Oct. 24, 2018). “Gene expression variability across cells and species shapes innate immunity,”
[cited by applicant]
Hamaday, M. et al. (Mar. 2008, e-published Feb. 10, 2008). “Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex,”
[cited by applicant]
Hamilton, N. (Aug. 2009, e-published Jul. 2, 2009). “Quantification and its applications in fluorescent microscopy imaging,”
[cited by applicant]
Hardenbol, P. et al. (Jun. 1, 2003, e-published May 5, 2003). “Multiplexed genotyping with sequence-tagged molecular inversion probes,”
[cited by applicant]
Heintzmann, R. et al. (Dec. 13, 2017, e-published Nov. 10, 2017). “Super-Resolution Structured Illumination Microscopy,”
[cited by applicant]
Hu, Y. et al. (Nov. 7, 2014, e-published Sep. 3, 2014). “Sensitive quantification of messenger RNA with a real-time ligase chain reaction by using a ribonucleotide-modified DNA probe,”
[cited by applicant]
International Search Report and Written Opinion mailed on Jan. 31, 2022, for PCT application PCT/US2021/045105, filed Aug. 6, 2021, 18 pages.
[cited by applicant]
International Search Report and Written Opinion mailed on Sep. 19, 2022, for PCT application PCT/US2022/027630, filed May 4, 2022, 13 pages.
[cited by applicant]
International Search Report and Written Opinion mailed on Nov. 23, 2021, for PCT Application No. PCT/US2021/045104, filed Aug. 6, 2021, 15 pages.
[cited by applicant]
Jeong, S. et al. (Apr. 2020, e-published Jan. 30, 2020). “Current immunoassay methods and their applications to clinically used biomarkers of breast cancer,”
[cited by applicant]
Kappler, K. et al. (Aug. 2020, e-published Aug. 5, 2020). “Emergence and significance of carbohydrate-specific antibodies,”
[cited by applicant]
Kato, M. et al. (Feb. 1, 1995, e-published May 1, 2002). “Polymerization of methyl methacrylate with the carbon tetrachloride/dichlorotris-(triphenylphosphine) ruthenium (II)/methylaluminum bis (2, 6-di-tert-butylphenox…
[cited by applicant]
Ke, R. et al. (Sep. 2013, e-published Jul. 14, 2003). “In situ sequencing for RNA analysis in preserved tissue and cells,”
[cited by applicant]
Klein A. M. et al. (Aug. 7, 2017, e-published Jul. 25, 2017). “InDrops and Drop-seq technologies for single-cell sequencing,”
[cited by applicant]
Kobori, T. et al. (2014). “Expanding possibilities of rolling circle amplification as a biosensing platform,”
[cited by applicant]
Krzywkowski, T. et al. (Oct. 2018). “Chimeric padlock and iLock probes for increased efficiency of targeted RNA detection,”
[cited by applicant]
Lage, J. M. et al. (Feb. 2003). “Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH,”
[cited by applicant]
Lareau, C. A. et al. (Feb. 13, 2020). “Inference and effects of barcode multiplets in droplet-based single-cell assays,”
[cited by applicant]
Larsson, C. et al. (May 2010, e-published Apr. 11, 2010). “In situ detection and genotyping of individual mRNA molecules,”
[cited by applicant]
Lee, J. H. et al. (Feb. 27, 2014, e-published Feb. 20, 2014). “Highly multiplexed subcellular RNA sequencing in situ,”
[cited by applicant]
Lee, J. H. et al. (Mar. 2015, e-published Feb. 12, 2015). “Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profillnq in intact cells and tissues,”
[cited by applicant]
Li, J. B. et al. (May 29, 2009). “Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing,”
[cited by applicant]
Li, J. B. et al. (Jun. 12, 2009). “Multiplex padlock targeted sequencing reveals human hypermutable CpG variations,”
[cited by applicant]
Li, N. et al. (Jun. 15, 2009, e-published May 21, 2009). “Stand-alone rolling circle amplification combined with capillary electrophoresis for specific detection of small RNA,”
[cited by applicant]
Lizardi, P. M. et al. (Jul. 1998). “Mutation detection and single-molecule counting using isothermal rolling-circle amplification,”
[cited by applicant]
Lohmann, J. S. et al. (Nov. 13, 2007). “Detection of short repeated genomic sequences on metaphase chromosomes using padlock probes and target primed rolling circle DNA synthesis,”
[cited by applicant]
Lubeck, E. et al. (Jul. 2012, e-published Jun. 3, 2012). “Single-cell systems biology by super-resolution imaging and combinatorial labeling,”
[cited by applicant]
Lubeck, E. et al. (Apr. 2014, e-published Mar. 28, 2014). “Single-cell in situ RNA profiling by sequential hybridization,”
[cited by applicant]
Lugagne, J-B. et al. (Jul. 30, 2018). “Identification of individual cells from z-stacks of bright-field microscopy images,”
[cited by applicant]
Lundin, E. et al. (Jan. 14, 2020). “Spatiotemporal mapping of RNA editing in the developing mouse brain using in situ sequencing reveals regional and cell-type-specific regulation,”
[cited by applicant]
Mag, M. et al. (Nov. 24, 1992, e-published Mar. 5, 2001). “Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged non-chiral internucleotide 3′-phosphoramidate linkage,”
[cited by applicant]
Manuguerra, I. et al. (May 1, 2018, e-published Apr. 17, 2018). “Gene assembly via one-pot chemical ligation of DNA promoted by DNA nanostructures,”
[cited by applicant]
Mignardi, M. et al. (Apr. 28, 2014). “Fourth-generation sequencing in the cell and the clinic,”
[cited by applicant]
Mirza, S. P. et al. (Mar. 1, 2008). “Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry,”
[cited by applicant]
Mitra, R.D. et al. (Sep. 1, 2003, e-published Jul. 15, 2003) “Fluorescent in situ sequencing on polymerase colonies,”
[cited by applicant]
Moad, G. et al. (Jun. 14, 2005). “Living radical polymerization by the RAFT process,”
[cited by applicant]
Mohammadi-Kambs, M. et al. (Apr. 30, 2017, e-published Apr. 5, 2017). “Hamming distance as a concept in DNA molecular recognition,”
[cited by applicant]
Nilsson, M. et al. (Sep. 30, 1994). “Padlock probes: circularizing oligonucleotides for localized DNA detection,”
[cited by applicant]
Nitta, H. et al. (Aug. 2013, e-published Nov. 15, 2015). “New methods for ALK status diagnosis in non-small-Cell lung Cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-In situ hybrid…
[cited by applicant]
Noggle, S. et al. (Oct. 6, 2011, e-published Oct. 5, 2011). “Human oocytes reprogram somatic cells to a pluripotent state,”
[cited by applicant]
Odeh, F. et al. (Dec. 18, 2019). “Aptamers Chemistry: Chemical Modifications and Conjugation Strategies,”
[cited by applicant]
Otsu, T. et al. (Feb. 16, 1982). “Role of initiator-transfer agent-terminator (iniferter) in radical polymerizations: Polymer design by organic disulfides as iniferters,”
[cited by applicant]
Ouladan, S. et al. (Jun. 2015, e-published Apr. 20, 2015). “Differential diagnosis of solitary fibrous tumors: A study of 454 soft tissue tumors indicating the diagnostic value of nuclear STAT6 relocation and ALDH1 expr…
[cited by applicant]
Park, M. S. et al. (May 11, 2013). “The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis,”
[cited by applicant]
Patel, A. P. et al. (Jun. 20, 2014, e-published Jun. 12, 2014). “Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma,”
[cited by applicant]
Pattarone, G. et al. (May 13, 2021, corrected Sep. 24, 2021). “Learning deep features for dead and living breast cancer cell classification without staining,”
[cited by applicant]
Pearson, A. et al. (Aug. 2016, e-published May 13, 2016). “High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial,”
[cited by applicant]
Peerzade, S. A. et al. (May 8, 2020). “Ultrabright Fluorescent Silica Nanoparticles for Multiplexed Detection,”
[cited by applicant]
Peters, J. M. et al. (Jan. 1, 2011). “Multiparameter flow cytometry in the diagnosis and management of acute leukemia,”
[cited by applicant]
Porreca, G. J. et al. (Nov. 2007, e-published Oct. 14, 2007). “Multiplex amplification of large sets of human exons,”
[cited by applicant]
Ronaghi, M. et al. (Nov. 1, 1996, e-published May 25, 2002). “Real-time DNA sequencing using detection of pyrophosphate release,”
[cited by applicant]
Ronaghi, M. et al. (Jul. 17, 1998). “A sequencing method based on real-time pyrophosphate,”
[cited by applicant]
Ronaghi, M. (Jan. 2001). “Pyrosequencing sheds light on DNA sequencing,”
[cited by applicant]
Rouhanifard, S. H. et al. (May 7, 2018). “Exponential fluorescent amplification of individual RNAs using clampFISH probes,”
[cited by applicant]
Sansone, A. (Jun. 2019, e-published May 30, 2019). “Spatial transcriptomics levels up,”
[cited by applicant]
Sapoznik, E. et al. (Nov. 12, 2020). “A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamics,”
[cited by applicant]
Schallmeiner, E. et al. (Feb. 1, 2007, e-published Dec. 17, 2006). “Sensitive protein detection via triple-binder proximity ligation assays,”
[cited by applicant]
Schlachter, S. et al. (2009). “A method to unmix multiple fluorophores in microscopy images with minimal a priori information,”
[cited by applicant]
Shendure, J. et al. (Sep. 9, 2005, e-published Aug. 4, 2005). “Accurate multiplex polony sequencing of an evolved bacterial genome,”
[cited by applicant]
Shirakawa, H. et al. (Mar. 2004). “Blind spectral decomposition of single-cell fluorescence by parallel factor analysis,”
[cited by applicant]
Strell, C. et al. (Apr. 2019, e-published Mar. 14, 2019). “Placing RNA in context and space-methods for spatially resolved transcriptomics,”
[cited by applicant]
Suzuki, A. et al. (Dec. 20, 2019). “Characterization of cancer omics and drug perturbations in panels of lung cancer cells,”
[cited by applicant]
Takahashi, H. et al. (May 17, 2018). “RNase H-assisted RNA-primed rolling circle amplification for targeted RNA sequence detection,”
[cited by applicant]
Tang, S. et al. (Aug. 2, 2016). “Suppression of rolling circle amplification by nucleotide analogs in circular template for three DNA polymerases,”
[cited by applicant]
The Stratagene Catalog (1988), p. 39.
[cited by applicant]
Turczyk, B. M. et al. (Jul. 2020). “Spatial sequencing: a perspective,”
[cited by applicant]
Van Der Velden, V. H. J. et al. (Jun. 2003). “Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects,”
[cited by applicant]
Veregin, R. P. N. et al. (Sep. 1, 1993, e-published May 1, 2002). “Free radical polymerizations for narrow polydispersity resins: electron spin resonance studies of the kinetics and mechanism,”
[cited by applicant]
Vickovic, S. et al. (Oct. 2019, e-published Sep. 9, 2019). “High-definition spatial transcriptomics for in situ tissue profiling,”
[cited by applicant]
Walker, J. W., et al. (Oct. 1, 1988, e-published May 1, 2002). “Photolabile 1-(2-nitrophenyl) ethyl phosphate esters of adenine nucleotide analogs. Synthesis and mechanism of photolysis,”
[cited by applicant]
Wang, G. et al. (Mar. 19, 2018). “Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy,”
[cited by applicant]
Wang, J-S. et al. (May 1, 1995, e-published May 1, 2002). “Controlled/‘living’ radical polymerization. atom transfer radical polymerization in the presence of transition-metal complexes,”
[cited by applicant]
Wang X. et al. (Jul. 27, 2018, e-published Jun. 21, 2018). “Three-dimensional intact-tissue sequencing of single-cell transcriptional states,”
[cited by applicant]
Wassie, A. T. et al. (Jan. 2009, e-published Dec. 20, 2018). “Expansion microscopy: principles and uses in biological research,”
[cited by applicant]
Weibrecht, I. et al. (Feb. 2013, e-published Jan. 24, 2013). “In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proxi…
[cited by applicant]
Wilson, C. S. et al. (Jul. 15, 2006, e-published Apr. 4, 2006). “Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction,”
[cited by applicant]
Xu, Q. et al. (Feb. 17, 2009). “Design of 240,000 orthogonal 25mer DNA barcode probes,”
[cited by applicant]
Yaari, G. et al. (Nov. 20, 2015). “Practical guidelines for B-cell receptor repertoire sequencing analysis,”
[cited by applicant]
Yeole, N. (Jun. 2010, e-published May 25, 2010). “Thiocarbonylthio compounds,”
[cited by applicant]
York, A. G. et al. (Nov. 2013, e-published Oct. 6, 2013). “Instant super-resolution imaging in live cells and embryos via analog image processing,”
[cited by applicant]
Zhang, K. et al. (Aug. 2009, e-published Jul. 20, 2009). “Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human,”
[cited by applicant]
Zheng, G. X. et al. (Jan. 16, 2017). “Massively parallel digital transcriptional profiling of single cells,”
[cited by applicant]
Cited By (1)